July 20, 2020 / 6:12 AM / in 22 days

GSK to take 10% stake in Germany's CureVac for $163 mln

July 20 (Reuters) - Britain’s GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work together on a novel type of vaccine that is also being tested for the coronavirus. ($1 = 0.7977 pounds) (Reporting by Pushkala Aripaka in Bengaluru; Editing by Vinay Dwivedi)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below